These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 19542943)

  • 1. Progressive osteoblastic bone metastases in breast cancer negative on FDG-PET.
    Huyge V; Garcia C; Vanderstappen A; Alexiou J; Gil T; Flamen P
    Clin Nucl Med; 2009 Jul; 34(7):417-20. PubMed ID: 19542943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer.
    Nakai T; Okuyama C; Kubota T; Yamada K; Ushijima Y; Taniike K; Suzuki T; Nishimura T
    Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1253-8. PubMed ID: 16133397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
    Du Y; Cullum I; Illidge TM; Ell PJ
    J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone metastases from breast cancer: associations between morphologic CT patterns and glycolytic activity on PET and bone scintigraphy as well as explorative search for influential factors.
    Sugihara T; Koizumi M; Koyama M; Terauchi T; Gomi N; Ito Y; Hatake K; Sata N
    Ann Nucl Med; 2017 Dec; 31(10):719-725. PubMed ID: 28864931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer.
    Hahn S; Heusner T; Kümmel S; Köninger A; Nagarajah J; Müller S; Boy C; Forsting M; Bockisch A; Antoch G; Stahl A
    Acta Radiol; 2011 Nov; 52(9):1009-14. PubMed ID: 21969709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of 18F-FDG-negative osteoblastic metastatic bone lesions noted on PET/CT in breast cancer patients.
    Al-Muqbel KM; Yaghan RJ; Al-Omari MH; Rousan LA; Dagher NM; Al Bashir S
    Nucl Med Commun; 2016 Jun; 37(6):593-601. PubMed ID: 26813990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography and bone metastases.
    Fogelman I; Cook G; Israel O; Van der Wall H
    Semin Nucl Med; 2005 Apr; 35(2):135-42. PubMed ID: 15765376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved detection of bone metastases from lung cancer in the thoracic cage using 5- and 1-mm axial images versus a new CT software generating rib unfolding images: comparison with standard ¹⁸F-FDG-PET/CT.
    Homann G; Mustafa DF; Ditt H; Spengler W; Kopp HG; Nikolaou K; Horger M
    Acad Radiol; 2015 Apr; 22(4):505-12. PubMed ID: 25586709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer.
    Uematsu T; Yuen S; Yukisawa S; Aramaki T; Morimoto N; Endo M; Furukawa H; Uchida Y; Watanabe J
    AJR Am J Roentgenol; 2005 Apr; 184(4):1266-73. PubMed ID: 15788608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions.
    Cook GJ; Houston S; Rubens R; Maisey MN; Fogelman I
    J Clin Oncol; 1998 Oct; 16(10):3375-9. PubMed ID: 9779715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F sodium fluoride PET/CT detects osseous metastases from breast cancer missed on FDG PET/CT with marrow rebound.
    Avery R; Kuo PH
    Clin Nucl Med; 2013 Sep; 38(9):746-8. PubMed ID: 23797230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG-avid sclerotic bone metastases in breast cancer patients: a PET/CT case series.
    Koolen BB; Vegt E; Rutgers EJ; Vogel WV; Stokkel MP; Hoefnagel CA; Fioole-Bruining A; Vrancken Peeters MJ; Valdés Olmos RA
    Ann Nucl Med; 2012 Jan; 26(1):86-91. PubMed ID: 21953212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disseminated osteomyelitis or bone metastases of breast cancer: (18)F-FDG-PET/CT helps unravel an unusual presentation.
    Mandegaran R; Debard A; Alvarez M; Marchou B; Massip P; Wagner T
    Ann Nucl Med; 2014 Feb; 28(2):167-71. PubMed ID: 24203488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer.
    De Giorgi U; Mego M; Rohren EM; Liu P; Handy BC; Reuben JM; Macapinlac HA; Hortobagyi GN; Cristofanilli M; Ueno NT
    J Nucl Med; 2010 Aug; 51(8):1213-8. PubMed ID: 20660382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of bone metastases in breast cancer by positron emission tomography.
    Schirrmeister H
    Radiol Clin North Am; 2007 Jul; 45(4):669-76, vi. PubMed ID: 17706531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of 18F-FDG-PET/CT vs Bone Scintigraphy in Treatment Response Assessment of Bone Metastases in Breast Cancer.
    Al-Muqbel KM; Yaghan RJ
    Medicine (Baltimore); 2016 May; 95(21):e3753. PubMed ID: 27227942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
    Gallowitsch HJ; Kresnik E; Gasser J; Kumnig G; Igerc I; Mikosch P; Lind P
    Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of bone scintigraphy and (18)F-FDG PET/CT in bone metastases of lung cancer patients].
    Portilla-Quattrociocchi H; Banzo I; Martínez-Rodríguez I; Quirce R; Jiménez-Bonilla J; de Arcocha Torres M; Medina-Quiroz P; del Castillo R; Rubio-Vassallo A; Carril JM
    Rev Esp Med Nucl; 2011; 30(1):2-7. PubMed ID: 21208693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
    Ak I; Sivrikoz MC; Entok E; Vardareli E
    Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heterogeneity of bone metastases in a patient with breast cancer: case report illustrating the potential of combining various imaging techniques].
    Withofs N; Collignon J; Rorive A; Jerusalem G; Hustinx R
    Rev Med Liege; 2011; 66(5-6):288-90. PubMed ID: 21826964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.